NCT03599310 is a NA clinical trial of Advance care planning in End Stage Disease, sponsored by Food and Health Bureau, Hong Kong.

Who is sponsoring NCT03599310?

NCT03599310 is sponsored by Food and Health Bureau, Hong Kong.

What drugs are being tested in NCT03599310?

Interventions in NCT03599310: Advance care planning, Usual care.

What condition does NCT03599310 study?

NCT03599310 studies End Stage Disease.

Is NCT03599310 still recruiting?

NCT03599310 is currently completed. Last updated 13 November 2019.

Last reviewed 2019-11-13 · How we verify

NCT03599310

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Structured Advance Care Planning Guide Among Patients With Advanced Illness in Hospital Care Settings

Completed NA Last updated 13 November 2019

What this trial tests

NA trial testing Advance care planning in End Stage Disease in 350 participants. Completed in 31 July 2019.

Timeline

1 August 2017

Primary endpoint
31 July 2019

31 July 2019

Quick facts

Lead sponsor	Food and Health Bureau, Hong Kong
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	health services research
Enrollment	350
Start date	1 August 2017
Primary completion	31 July 2019
Estimated completion	31 July 2019
Sites	1 location across Hong Kong

Drugs / interventions tested

Advance care planning
Usual care

Conditions studied

End Stage Disease — all drugs for End Stage Disease →

Sponsor

Food and Health Bureau, Hong Kong

Who can join

18 and older, any sex, with End Stage Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: To examine the effects of a structured advance care planning (ACP) guide among patients with advanced illness in hospital care setting. Methods: This is a 24-month stepped-wedge cluster randomised controlled trial to be conducted in the Department of Medicine in an acute hospital. Patients are eligible to the study if they are aged 18 or over, are communicable, and meet the indicators of health deterioration or advanced condition in the Supportive and Palliative Care Indicators Tool (SPICT). Ward nurses will be trained to be interventionists to conduct ACP by means of a structured ACP guide. The guide is adapted from a culturally sensitive ACP programme developed in the local context with reference to the format of the Serious Illness Communication Guide, which is an evidence-based best practice in end-of-life care communication to support the ACP process. Main outcome measures: Data will be collected at baseline (T0), one week (T1), three months (T2) and six months (T3) after intervention. The primary study outcome is the documentation of ACP discussion in medical records and completion of advance directives. Secondary outcomes are communicating end-of-life care preferences with family carers, quality of life and concordance of care preferences and treatment provided.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for End Stage Disease

Currently open trials in the same condition.

NCT04778761 — ACP Video Intervention for Patients With Life-Limiting Illness · NA · recruiting

Other Food and Health Bureau, Hong Kong trials

Trials by the same sponsor.

NCT06008210 — A Decision Aid on End-of-life Care for Patients With Advanced COPD and Their Family · NA · completed
NCT05422729 — mHealth-supported Coach · NA · unknown
NCT04352387 — Montessori Based Activities for Dementia · NA · completed
NCT04162912 — Motivational Interviewing Tailored Programme for Promoting Advance Care Planning Behaviours · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03599310 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Food and Health Bureau, Hong Kong
Last refreshed: 13 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03599310.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing